Hans Ghayee, DO, discusses pheochromocytoma and paraganglioma. He offers information on evaluation and management, ongoing research studies and he shares his research at UF Health Shands Hospital

In this episode, Christina Wilson, MD, compares and contrasts alteplase and tenecteplase for acute ischemic stroke. She characterizes the population of stroke patients that may benefit most from tenecteplase treatment and she helps us to recognize potential barriers to tenecteplase implementation.

Jeffrey Friedman, MD, FACS, discusses the options for medically supervised weight loss, including surgery and the surgical options available at UF Health Shands Hospital. He shares the importance of vitamins and examines research on the transdermal vitamin patch post-surgery.

Bently Doonan, MD, examines emerging therapies for metastatic melanoma. He identifies LAG3 inhibition and its role in melanoma. He helps to familiarize physicians with TIL therapy and he discusses outpatient systemic cytokine therapy for relapsed metastatic melanoma

Kenneth Cusi MD, FACP, FACE, discusses the practical clinical care pathway for non-alcoholic fatty liver disease (NAFLD). He helps us understand the magnitude of the epidemic on NAFLD and what it means to primary care physicians and patients. He defines who is at risk, how to screen and when to refer to a liver specialist. Additionally, he examines what treatments are available today and what is coming in the drug development pipeline.

Adolfo Ramirez-Zamora, MD, discusses the challenges when it comes to diversity when treating Parkinson's Disease. He shares how to recognize the clinical symptoms of Parkinson’s Disease, characterizes the challenges that diverse populations experience when seeking care and discusses ideas on how to increase diversity in clinical practices.

Bashar Alzghoul MD and Hiren Mehta, MD discuss COVID-19 from intensive care unit to outpatient clinic. They help us to understand the best practices and standard of care for COVID-19 patients in the ICU. They examine available literature about long-term care/outpatient care for COVID-19 patients, the care provided at UF and available resources for long term management of post COVID-19 fibrosis including lung transplantation

Wayne Brisbane M.D. gives an overview of prostate cancer focal therapy. He differentiates prostate cancer focal therapy from whole-gland therapy. He helps to understand the limitations of focal therapy and he characterizes the ideal patient for this innovative therapy.

Ali Zarrinpar, MD, Brian Ramnaraign, MD, Steven Hughes, MD, and Kathryn Hitchcock, MD, discuss neuroendocrine tumor (NET) management – the state of the art in 2021, including PRRT.
They give an overview of the current management of neuroendocrine tumors. They describe the use of peptide receptor radionuclide therapy for treatment for NETs and they explain when, in the course of the disease, PRRT is best given